212 related articles for article (PubMed ID: 38466778)
1. Rational Design of TDP-43 Derived α-Helical Peptide Inhibitors: An
Salaikumaran MR; Gopal PP
ACS Chem Neurosci; 2024 Mar; 15(6):1096-1109. PubMed ID: 38466778
[TBL] [Abstract][Full Text] [Related]
2. Rational Design of TDP-43 Derived α-Helical Peptide Inhibitors: an
Salaikumaran MR; Gopal PP
bioRxiv; 2023 Oct; ():. PubMed ID: 37961353
[TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of thermal unfolding simulations of RNA recognition motifs (RRMs) of TAR DNA-binding protein 43 (TDP-43).
Prakash A; Kumar V; Meena NK; Hassan MI; Lynn AM
J Biomol Struct Dyn; 2019 Jan; 37(1):178-194. PubMed ID: 29279008
[TBL] [Abstract][Full Text] [Related]
4. Exploring the aggregation-prone regions from structural domains of human TDP-43.
Kumar V; Wahiduzzaman ; Prakash A; Tomar AK; Srivastava A; Kundu B; Lynn AM; Imtaiyaz Hassan M
Biochim Biophys Acta Proteins Proteom; 2019 Mar; 1867(3):286-296. PubMed ID: 30315897
[TBL] [Abstract][Full Text] [Related]
5. Seeding the aggregation of TDP-43 requires post-fibrillization proteolytic cleavage.
Kumar ST; Nazarov S; Porta S; Maharjan N; Cendrowska U; Kabani M; Finamore F; Xu Y; Lee VM; Lashuel HA
Nat Neurosci; 2023 Jun; 26(6):983-996. PubMed ID: 37248338
[TBL] [Abstract][Full Text] [Related]
6. TDP-43 α-helical structure tunes liquid-liquid phase separation and function.
Conicella AE; Dignon GL; Zerze GH; Schmidt HB; D'Ordine AM; Kim YC; Rohatgi R; Ayala YM; Mittal J; Fawzi NL
Proc Natl Acad Sci U S A; 2020 Mar; 117(11):5883-5894. PubMed ID: 32132204
[TBL] [Abstract][Full Text] [Related]
7. A Computational Approach to Investigate TDP-43 RNA-Recognition Motif 2 C-Terminal Fragments Aggregation in Amyotrophic Lateral Sclerosis.
Grassmann G; Miotto M; Di Rienzo L; Salaris F; Silvestri B; Zacco E; Rosa A; Tartaglia GG; Ruocco G; Milanetti E
Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944548
[TBL] [Abstract][Full Text] [Related]
8. Dissecting the effect of ALS mutation S375G on the conformational properties and aggregation dynamics of TDP-43
Xu Z; Zhang J; Tang J; Gong Y; Zou Y; Zhang Q
Biophys Chem; 2024 Jul; 310():107230. PubMed ID: 38615537
[TBL] [Abstract][Full Text] [Related]
9. TDP-43 and Tau Oligomers in Alzheimer's Disease, Amyotrophic Lateral Sclerosis, and Frontotemporal Dementia.
Montalbano M; McAllen S; Cascio FL; Sengupta U; Garcia S; Bhatt N; Ellsworth A; Heidelman EA; Johnson OD; Doskocil S; Kayed R
Neurobiol Dis; 2020 Dec; 146():105130. PubMed ID: 33065281
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapy targeting the C-terminal domain of TDP-43 decreases neuropathology and confers neuroprotection in mouse models of ALS/FTD.
Afroz T; Chevalier E; Audrain M; Dumayne C; Ziehm T; Moser R; Egesipe AL; Mottier L; Ratnam M; Neumann M; Havas D; Ollier R; Piorkowska K; Chauhan M; Silva AB; Thapa S; Stöhr J; Bavdek A; Eligert V; Adolfsson O; Nelson PT; Porta S; Lee VM; Pfeifer A; Kosco-Vilbois M; Seredenina T
Neurobiol Dis; 2023 Apr; 179():106050. PubMed ID: 36809847
[TBL] [Abstract][Full Text] [Related]
11. ALS Mutations Disrupt Phase Separation Mediated by α-Helical Structure in the TDP-43 Low-Complexity C-Terminal Domain.
Conicella AE; Zerze GH; Mittal J; Fawzi NL
Structure; 2016 Sep; 24(9):1537-49. PubMed ID: 27545621
[TBL] [Abstract][Full Text] [Related]
12. Structure of pathological TDP-43 filaments from ALS with FTLD.
Arseni D; Hasegawa M; Murzin AG; Kametani F; Arai M; Yoshida M; Ryskeldi-Falcon B
Nature; 2022 Jan; 601(7891):139-143. PubMed ID: 34880495
[TBL] [Abstract][Full Text] [Related]
13. Functional and dynamic polymerization of the ALS-linked protein TDP-43 antagonizes its pathologic aggregation.
Afroz T; Hock EM; Ernst P; Foglieni C; Jambeau M; Gilhespy LAB; Laferriere F; Maniecka Z; Plückthun A; Mittl P; Paganetti P; Allain FHT; Polymenidou M
Nat Commun; 2017 Jun; 8(1):45. PubMed ID: 28663553
[TBL] [Abstract][Full Text] [Related]
14. ALS-Causing Mutations Significantly Perturb the Self-Assembly and Interaction with Nucleic Acid of the Intrinsically Disordered Prion-Like Domain of TDP-43.
Lim L; Wei Y; Lu Y; Song J
PLoS Biol; 2016 Jan; 14(1):e1002338. PubMed ID: 26735904
[TBL] [Abstract][Full Text] [Related]
15. Point mutations in the N-terminal domain of transactive response DNA-binding protein 43 kDa (TDP-43) compromise its stability, dimerization, and functions.
Mompeán M; Romano V; Pantoja-Uceda D; Stuani C; Baralle FE; Buratti E; Laurents DV
J Biol Chem; 2017 Jul; 292(28):11992-12006. PubMed ID: 28566288
[TBL] [Abstract][Full Text] [Related]
16. TDP-43 regulates the alternative splicing of hnRNP A1 to yield an aggregation-prone variant in amyotrophic lateral sclerosis.
Deshaies JE; Shkreta L; Moszczynski AJ; Sidibé H; Semmler S; Fouillen A; Bennett ER; Bekenstein U; Destroismaisons L; Toutant J; Delmotte Q; Volkening K; Stabile S; Aulas A; Khalfallah Y; Soreq H; Nanci A; Strong MJ; Chabot B; Vande Velde C
Brain; 2018 May; 141(5):1320-1333. PubMed ID: 29562314
[TBL] [Abstract][Full Text] [Related]
17. Defective cyclophilin A induces TDP-43 proteinopathy: implications for amyotrophic lateral sclerosis and frontotemporal dementia.
Pasetto L; Grassano M; Pozzi S; Luotti S; Sammali E; Migazzi A; Basso M; Spagnolli G; Biasini E; Micotti E; Cerovic M; Carli M; Forloni G; De Marco G; Manera U; Moglia C; Mora G; Traynor BJ; Chiò A; Calvo A; Bonetto V
Brain; 2021 Dec; 144(12):3710-3726. PubMed ID: 34972208
[TBL] [Abstract][Full Text] [Related]
18. The amyloidogenicity of a C-terminal region of TDP-43 implicated in Amyotrophic Lateral Sclerosis can be affected by anions, acetylation and homodimerization.
Prasad A; Sivalingam V; Bharathi V; Girdhar A; Patel BK
Biochimie; 2018 Jul; 150():76-87. PubMed ID: 29751083
[TBL] [Abstract][Full Text] [Related]
19. Tethering-induced destabilization and ATP-binding for tandem RRM domains of ALS-causing TDP-43 and hnRNPA1.
Dang M; Li Y; Song J
Sci Rep; 2021 Jan; 11(1):1034. PubMed ID: 33441818
[TBL] [Abstract][Full Text] [Related]
20. An Amyloid-Like Pathological Conformation of TDP-43 Is Stabilized by Hypercooperative Hydrogen Bonds.
Mompeán M; Baralle M; Buratti E; Laurents DV
Front Mol Neurosci; 2016; 9():125. PubMed ID: 27909398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
